DK1341758T3 - Coniosetin og derivater af denne, fremgangsmåde til fremstilling og anvendelse af samme - Google Patents

Coniosetin og derivater af denne, fremgangsmåde til fremstilling og anvendelse af samme

Info

Publication number
DK1341758T3
DK1341758T3 DK01989546T DK01989546T DK1341758T3 DK 1341758 T3 DK1341758 T3 DK 1341758T3 DK 01989546 T DK01989546 T DK 01989546T DK 01989546 T DK01989546 T DK 01989546T DK 1341758 T3 DK1341758 T3 DK 1341758T3
Authority
DK
Denmark
Prior art keywords
coniosetin
derivatives
preparation
same
Prior art date
Application number
DK01989546T
Other languages
Danish (da)
English (en)
Inventor
Laszlo Vertesy
Astrid Markus
Martin Knauf
Luigi Toti
Mark-Cecile Raynal-Wetzel
Florence Fassy
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Application granted granted Critical
Publication of DK1341758T3 publication Critical patent/DK1341758T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/44Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK01989546T 2000-12-07 2001-11-30 Coniosetin og derivater af denne, fremgangsmåde til fremstilling og anvendelse af samme DK1341758T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10060810A DE10060810A1 (de) 2000-12-07 2000-12-07 Coniosetin und Derivate davon, Verfahren zur Herstellung und Verwendung derselben

Publications (1)

Publication Number Publication Date
DK1341758T3 true DK1341758T3 (da) 2006-10-30

Family

ID=7666132

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01989546T DK1341758T3 (da) 2000-12-07 2001-11-30 Coniosetin og derivater af denne, fremgangsmåde til fremstilling og anvendelse af samme

Country Status (15)

Country Link
US (1) US6599930B2 (xx)
EP (1) EP1341758B1 (xx)
JP (1) JP4057910B2 (xx)
AR (1) AR033685A1 (xx)
AT (1) ATE331706T1 (xx)
AU (2) AU2002227966B2 (xx)
CA (1) CA2430827C (xx)
CY (1) CY1105292T1 (xx)
DE (2) DE10060810A1 (xx)
DK (1) DK1341758T3 (xx)
ES (1) ES2266298T3 (xx)
IL (2) IL156162A0 (xx)
MX (1) MXPA03004849A (xx)
PT (1) PT1341758E (xx)
WO (1) WO2002046152A2 (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10146737A1 (de) 2001-09-22 2003-04-10 Aventis Pharma Gmbh Coniosulfide und deren Derivate, Verfahren zu ihrer Herstellung und Verwendung als Arzneimittel
US6962943B2 (en) 2001-11-21 2005-11-08 Aventis Pharma Deutschland Gmbh Gabusectin derivatives, processes for preparing them and their use
DE10156906A1 (de) * 2001-11-21 2003-05-28 Aventis Pharma Gmbh Gabusectin-Derivate, Verfahren zu deren Herstellung und deren Verwendung
BRPI0410886A (pt) * 2003-06-03 2006-07-04 Isis Pharmaceuticals Inc composto de filamento duplo, composição farmacêutica, sal farmaceuticamente aceitável, métodos de modificação do ácido nucleico que codifica a survivina humana, de inibição da expressão da suvivina em células ou tecidos, e de tratamento de uma condição associada com a expressão ou superexpressão da suvivina, e, oligonucleotìdeo de rnai de filamento único
WO2009035553A2 (en) * 2007-09-11 2009-03-19 University Of Tennessee Research Foundation Analogs of tetramic acid
CN105331668B (zh) * 2015-10-27 2018-08-31 昆明理工大学 一种生物转化三七总皂苷制备人参皂苷Rd的方法
CN113755347B (zh) * 2021-10-20 2023-07-28 王晓艳 一种促进油茶氮素吸收的内生真菌am1

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3959468A (en) * 1974-05-06 1976-05-25 The United States Of America As Represented By The Secretary Of Agriculture Antibiotic equisetin and method of production
GB2306476A (en) * 1995-10-27 1997-05-07 Merck & Co Inc Hiv integrase inhibitors
US5759842A (en) * 1996-10-24 1998-06-02 Merck & Co., Inc. In vitro HIV integrase inhibitors
EP1129208B1 (en) 1998-11-09 2002-10-09 Aventis Pharma Deutschland GmbH Vancoresmycin, a process for its production and its use as a pharmaceutical

Also Published As

Publication number Publication date
ATE331706T1 (de) 2006-07-15
AU2002227966B2 (en) 2006-08-03
US6599930B2 (en) 2003-07-29
ES2266298T3 (es) 2007-03-01
US20020137788A1 (en) 2002-09-26
DE50110363D1 (de) 2006-08-10
JP2004515490A (ja) 2004-05-27
EP1341758B1 (de) 2006-06-28
CA2430827C (en) 2010-02-09
AU2796602A (en) 2002-06-18
AR033685A1 (es) 2004-01-07
CY1105292T1 (el) 2010-03-03
EP1341758A2 (de) 2003-09-10
DE10060810A1 (de) 2002-06-20
IL156162A (en) 2008-08-07
PT1341758E (pt) 2006-09-29
JP4057910B2 (ja) 2008-03-05
IL156162A0 (en) 2003-12-23
WO2002046152A3 (de) 2002-11-21
WO2002046152A2 (de) 2002-06-13
MXPA03004849A (es) 2003-08-19
CA2430827A1 (en) 2002-06-13

Similar Documents

Publication Publication Date Title
DK1180518T3 (da) 5-pyridyl-1,3-azolforbindelser, fremgangsmåde til fremstilling deraf og anvendelse deraf
DK1345910T3 (da) Quinazolinderivater, lægemidler indeholdende forbindelserne, deres anvendelse og fremgangsmåde til fremstilling deraf
NO20012158D0 (no) Substituerte 2-fenylbenzimidazoler, fremgangsmåte til fremstilling og anvendelse derav
DK1296935T3 (da) Fremgangsmåde til fremstilling af substituerede octanoylamider
NO20024175D0 (no) Azetidinderivater, deres fremstilling og farmasöytiske forbindelser inneholdende de samme
CY2007029I2 (el) Μεθοδος για την παρασκευη υποκατεστημενων οκτανοϋλ-αμιδιων
NO20022176D0 (no) Absorberende gjenstand og fremgangsmåte for fremstilling av denne
DK1147083T3 (da) Arylpiperazinyl-cyclohexylindolderivater til behandling af depression
DK1309545T3 (da) Fremgangsmåde til fremstilling af alkylarylsulfonater
DK1265482T3 (da) Vandige formulationer og fremgangsmåde til fremstilling af samme
IS6531A (is) Aðferðir til að búa til klaríþrómýsín og klaríþrómýsínmilliefni, í megindráttum oxímlaust klaríþrómýsín og lyfjablanda sem inniheldur það
NO20032332D0 (no) Benzodiazepinderivatforbindelser, fremgangsmåte til fremstilling og anvendelse derav
DK1261697T3 (da) Kuldeaktiv beta-galactosidase, fremgangsmåde til fremstilling heraf og anvendelsen deraf
NO20030800L (no) Aminoalkylbenzoyl-benzofuran- eller benzotiofenderivater, fremgangsmåte forderes fremstilling og preparater inneholdende de samme
NO20022834L (no) Zeolitt SSZ-50, fremgangsmåte for fremstilling og anvendelse av denne
DK1138677T3 (da) Fremgangsmåde til fremstilling af 11-amino-3-chlor-6,11-dihydro-5,5-dioxo-6-methyl-dibenzo[c,f][1,2]-thiazepin og anvendelse til syntese af tianeptin
DK1399424T3 (da) Fremgangsmåde til fremstilling af 10,11-dihydro-10-hydroxy-5H-dibenz[b,f]azepin-5-carboxamid og 10,11-dihydro-10-oxo-5H-dibenz[b,f]azepin-5-carboxamid
NO20013735L (no) Fremgangsmåte til fremstilling av di-iso-butaner, di-iso- butener og di-n-butener fra feltbutaner
DK1456229T3 (da) Fremgangsmåe til fremstilling af echinocandin-derivater
DK1341758T3 (da) Coniosetin og derivater af denne, fremgangsmåde til fremstilling og anvendelse af samme
NO20024105D0 (no) Memnopeptider, fremgangsmåte for deres fremstilling og anvendelse av disse
DK1294694T3 (da) Fremgangsmåde til fremstilling af quinolinderivater
NO20030515L (no) Fremgangsmåte for fremstilling av dinapsolin
NO20020308D0 (no) Fremgangsmåte for fremstilling av epothiolon B og derivater, såvel som mellomprodukter for fremgangsmåten
NO20033965L (no) Caloporosidderivater, fremgangsmåte for deres fremstilling og deres anvendelse